Herd immunity is not a new term. We know there is risk, controversy, and misinformation associated with vaccines. For this discussion, we will focus on Herd immunity and economics associated with disease management. Globally, many health experts are working to understand disease origin, progression, and the overall financial impacts of disease management. When it comes to pandemics such as COVID-19, what is the economic difference between treatments with preventative measures (vaccines) versus treating patients post infection for complications as needed? What makes the most economic sense as we move toward the goal of herd immunity?

Herd immunity is not a new term. We know there is risk, controversy, and misinformation associated with vaccines. For this discussion, we will focus on Herd immunity and economics associated with disease management. Globally, many health experts are working to understand disease origin, progression, and the overall financial impacts of disease management. When it comes to pandemics such as COVID-19, what is the economic difference between treatments with preventative measures (vaccines) versus treating patients post infection for complications as needed? What makes the most economic sense as we move toward the goal of herd immunity?

EBK HEALTH ECONOMICS AND POLICY

7th Edition

ISBN:9781337668279

Author:Henderson

Publisher:Henderson

Chapter4: Economic Evaluation In Health Care

Section: Chapter Questions

Problem 1QAP

See similar textbooks

Similar questions

Due to an increased number of patients seeking COVID-19 tests and counseling, the clinic and the counseling centre at the leading public hospital was converted to provide both health screening services and counseling services. Using all of its staff, the clinic can screen a maximum of 10 clients or it can counsel 6 clients. Using all of its staff, the counseling centre can screen a maximum of 6 clients or counsel 12 clients. Who has the absolute advantage in health screening? Who has the absolute advantage in counseling services? Who has a comparative advantage in health screening? Who has a comparative advantage in counseling services? What is the opportunity cost of counseling services?
Due to an increased number of patients seeking covid-19 tests and counselling, the clinic and the counselling centre at the hospital was converted to provide both health screening services and counselling services. Using all of its staff, the clinic can screen a maximum of 10 persons or it can counsel 6 persons. Using all of its staff, the counselling centre can screen a maximum of 6 persons or counsel 12 persons. Explain who has the absoulte advantage in health screening and who has the absoulte advantage in counselling services. Also explain who has the comparative advantage in health screening and who has the compartive advantage in counselling services. What is the opportunity cost of counselling services?
An empirically testable hypothesis for additional health care expenditure as an investment rather than as an expense is: a. If an increase in health care expenditure today results in an increase in productivity tomorrow, then health careexpenditure has an investment effect. b. If an increase in health care expenditure today results in an a rise in health care stock prices, then health care expenditure has an investment effect. c. If an increase in health care expenditure today results in worse health outcomes today, then health care expenditure has an investment effect. d. If an increase in health care expenditure today results in a more competitive health care market tomorrow, then health care expenditure has an investment effect.
As the COVID-19 crisis continues to deepen, the significant health and economic consequences of this disease is cripplingeven the most developed nations. With < 0.5% of globally confirmed cases occurring in Africa, the continent appears so farto be relatively spared the untoward direct health consequences of the COVID-19 pandemic. The disease nonetheless hasalready had a destabilizing effect on the lives of millions of Africans with disproportionate impact on the poor andunderserved. The interconnectedness that characterizes globalization has brought economic benefits to many Africancountries. With COVID-19, there have been disruptions in Africa’s global supply chains in the face of tumbling oil prices anda lowered global demand for African non-oil products, which constitutes a threat to the economic stability of the continent.Projected losses from oil shocks alone may result in a reduction in Africa’s export revenues by about US$101 billion in2020.This dip in oil prices will…
For which of the following reasons is the severity of the COVID-19 pandemic in developing countries likely being underestimated? Check all that apply Group of answer choices Vaccination rates are significantly lower in developing countries, suggesting that the situation will likely worsen for developing countries relative to developed countries over time Because developing countries have younger populations, the mortality rates from COVID are higher than they are for developed countries with larger old-age populations Even though more people live in developed countries, there are higher country-by-country mortality rates in developing countries More people live in developing countries, meaning that even though mortality rates by country may be lower, developing countries are still contributing a majority of global deaths due to the disease Reported deaths from COVID in the poorest countries are very low despite evidence of significant increases in mortality since the pandemic…
One of the key provisions of the Affordable Care Act was the ensuring coverage for “pre- existing conditions,” which had formerly been excluded from insurance plans as people with known medical conditions that will require treatment with certainty, the costs of which are virtually guaranteed to be more than the premiums that insurance companies could charge Suppose we have a population of patients with different health profiles, so that the cost of future treatment X is uniformly distributed on the interval [0, 1000], X˜ ∼ U [0, 1000]. Suppose that we have an insurance company that is bound to offer the same plan to all customers who wish to buy it and cannot deny coverage based on pre-existing conditions. The market for insurance is competitive, so that the insurance company must set its premium equal to the expected future payout. P = E[X˜] Another key provision of the ACA was the “individual mandate,” which required…
Question Prior to the outbreak of COVID-19, the US spends less than 5% of overall health care spending on public health related services/programs. True False
Indicate whether the statement is true or false, and justify your answer.In real life, investments in health can generate long-lasting benefits, but the Grossman model neglects this aspect of health.
While randomized control trials are gold-standard, we don't use them in economics often to explore causal relationships. Why? Provide three reasons.
Economic Epidemiology Suppose that some members of a population are infected with a sexually transmitted virus that causes disease X, and some are infected with another sexually transmitted virus that causes disease Y. Some members of the population may be infected with both viruses. While diseases X and Y are similar in that they are both sexually transmitted diseases, the disease X is much more harmful to its carriers than the disease Y is to its carriers. Condom use is highly effective in preventing the transmission of either disease. Suppose scientists discover a cure for the sexually transmitted disease X. This cure (a vaccination) will eliminate the virus causing the disease X from its carrier before its carrier can suffer any harm from the virus. Everybody is immediately given this vaccination against the disease X. a What do you expect to happen to the prevalence of the virus causing the disease X in the population? Draw a graph with time on the horizontal axis and prevalence…
Compare and contrast two quantitative tools for decision-making in conditions of certainty
Assume that people receiving intervention A live 5 years at quality of life of 0.8 and people receiving intervention B live 10 years at quality of life of 0.4. Assume further that the two intervention have equal costs. Compare the cost-effectiveness of these interventions relative to each other and discuss how that would be altered by inclusion of future costs for younger adults and older adults.